This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm of middle ear and respiratory system (controls excluding all cancers)
CD2_BENIGN_EAR_RESP_EXALLC
No definition available.
Endpoint definition
↥individuals
Apply sex-specific rule None
Check conditions None
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
-
Check minimum number of events None
-
Include endpoints
-
Remove individuals based on genotype QC
2485
Control definitions
Extra metadata
No upset plot: script not run.
No upset table: script not run.
Similar endpoints
↥List of similar endpoints to Benign neoplasm of middle ear and respiratory system (controls excluding all cancers) based on the number of shared cases.
Broader endpoints:
- Benign neoplasm of middle ear and respiratory system
- Benign neoplasms
- Benign neoplasms (controls excluding all cancers)
- Neoplasms
- Any event in hilmo or specialist outpatient
Narrower endpoints:
Summary Statistics
↥Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 2485 | 1026 | 1459 |
Unadjusted prevalence (%) | 0.60 | 0.45 | 0.80 |
Mean age at first event (years) | 54.76 | 51.45 | 57.10 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: CD2_BENIGN_EAR_RESP_EXALLC – Benign neoplasm of middle ear and respiratory system (controls excluding all cancers)
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Benign neoplasm of middle ear and respiratory system (controls excluding all cancers)
↥Endpoint not on priority list, no data to show.